| 【Company Research】361 Degrees (1361 HK) - The cautious outlook is likely priced in |
| 【Company Research】Ke Holdings (BEKE US) - Solid market share gains amid uncertain environment |
| 【Company Research】Rimag Group (2522 HK) - A leading medical imaging service provider in China |
| 【Company Research】Hua Hong Semi (1347 HK) - Slowly but surely, gradual recovery is in play |
| 【行业研究】中国医药 - 反弹趋势基本确定，业绩有望复苏 |
| 【公司研究】三生制药 (1530 HK) - 核心品种增长稳健，创新产品迎来收获；首予买入 |
| 【Company Research】BeiGene (BGNE US) - Sales exceeding expectations and achieving non-GAAP profitability |
| 【Company Research】Horizon CD (9930 HK) - Back to capex growth model to achieve product diversification & overseas expansion |
| 【公司研究】中际旭创 (300308 CH) - 强劲基本面无惧市场波动，重申买入评级 |
| 【Company Research】Yum China (YUMC US) - The best-in-class costs management in 2Q24 |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
